https://www.indianpharmapost.com/philogen-withdraws-marketing-authorization-application-for-nidlegy-in-eu-173122025-06-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-pathlabs-strengthens-its-genomics-capabilities-with-illuminas-novaseq-x-series-173132025-06-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/ashland-expands-viatel-bioresorbable-polymers-offering-for-medical-devices-173142025-06-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/teijin-pharma-receives-approval-for-additional-indication-for-xeomin-in-japan-173152025-06-26T00:00:00+05:30always0.9